|
AIDA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92579999946929E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.59770000000204E-05 |
| Normal-vs-Stage2 |
1.549640E-02 |
| Normal-vs-Stage3 |
2.415700E-04 |
| Normal-vs-Stage4 |
3.338100E-02 |
| Stage1-vs-Stage2 |
4.610800E-01 |
| Stage1-vs-Stage3 |
3.420000E-02 |
| Stage1-vs-Stage4 |
1.601210E-01 |
| Stage2-vs-Stage3 |
5.486800E-01 |
| Stage2-vs-Stage4 |
2.526000E-01 |
| Stage3-vs-Stage4 |
3.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81030000048865E-07 |
| Normal-vs-AfricanAmerican |
3.153300E-04 |
| Normal-vs-Asian |
1.338990E-01 |
| Caucasian-vs-AfricanAmerican |
5.539400E-01 |
| Caucasian-vs-Asian |
5.041800E-01 |
| AfricanAmerican-vs-Asian |
5.911600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.96009999995106E-06 |
| Normal-vs-Female |
2.04839999962125E-07 |
| Male-vs-Female |
2.777800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.194700E-04 |
| Normal-vs-Extreme_Weight |
3.57710000000733E-05 |
| Normal-vs-Obese |
4.68769999995011E-06 |
| Normal-vs-Extreme_Obese |
5.572400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.219600E-01 |
| Normal_Weight-vs-Obese |
6.975400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.330640E-01 |
| Extreme_Weight-vs-Obese |
2.052200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.020820E-01 |
| Obese-vs-Extreme_Obese |
6.662400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.941700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.27650000359259E-08 |
| Normal-vs-Age(61-80Yrs) |
9.5265000000011E-05 |
| Normal-vs-Age(81-100Yrs) |
2.307000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.565630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.230400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.808000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.059700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.042000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.286600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.36299999953238E-07 |
| Normal-VS-Type2 PRCC |
1.498010E-02 |
| Normal-VS-KIRP CIMP |
3.39879999999848E-06 |
| Normal-VS-Unclassified PRCC |
1.017730E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.158100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.16010542786194E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
2.451200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.83930032000058E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
6.475200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.61190005366319E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.495700E-02 |
| Normal-vs-N1 |
5.95639999999564E-05 |
| Normal-vs-N2 |
5.3550000000957E-07 |
| N0-vs-N1 |
1.384080E-03 |
| N0-vs-N2 |
4.219900E-03 |
| N1-vs-N2 |
7.952000E-01 |
|
|
